Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Effects of S 38093, an antagonist/inverse agonist of histamine H3 receptors, in models of neuropathic pain in rats.

Chaumette T, Chapuy E, Berrocoso E, Llorca-Torralba M, Bravo L, Mico JA, Chalus M, Eschalier A, Ardid D, Marchand F, Sors A.

Eur J Pain. 2018 Jan;22(1):127-141. doi: 10.1002/ejp.1097. Epub 2017 Sep 6.

PMID:
28877402
2.

Disruption of 5-HT2A-PDZ protein interaction differently affects the analgesic efficacy of SSRI, SNRI and TCA in the treatment of traumatic neuropathic pain in rats.

Wattiez AS, Dupuis A, Privat AM, Chalus M, Chapuy E, Aissouni Y, Eschalier A, Courteix C.

Neuropharmacology. 2017 Oct;125:308-318. doi: 10.1016/j.neuropharm.2017.07.034. Epub 2017 Aug 2.

PMID:
28780039
3.

Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity.

Vivier D, Soussia IB, Rodrigues N, Lolignier S, Devilliers M, Chatelain FC, Prival L, Chapuy E, Bourdier G, Bennis K, Lesage F, Eschalier A, Busserolles J, Ducki S.

J Med Chem. 2017 Feb 9;60(3):1076-1088. doi: 10.1021/acs.jmedchem.6b01285. Epub 2017 Jan 20.

PMID:
28051863
4.

Agomelatine: a new opportunity to reduce neuropathic pain-preclinical evidence.

Chenaf C, Chapuy E, Libert F, Marchand F, Courteix C, Bertrand M, Gabriel C, Mocaër E, Eschalier A, Authier N.

Pain. 2017 Jan;158(1):149-160.

PMID:
27984527
5.

The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia.

Lolignier S, Bonnet C, Gaudioso C, Noël J, Ruel J, Amsalem M, Ferrier J, Rodat-Despoix L, Bouvier V, Aissouni Y, Prival L, Chapuy E, Padilla F, Eschalier A, Delmas P, Busserolles J.

Cell Rep. 2015 May 19;11(7):1067-78. doi: 10.1016/j.celrep.2015.04.027. Epub 2015 May 7.

6.

Synthesis and structure-activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel.

Rodrigues N, Bennis K, Vivier D, Pereira V, C Chatelain F, Chapuy E, Deokar H, Busserolles J, Lesage F, Eschalier A, Ducki S.

Eur J Med Chem. 2014 Mar 21;75:391-402. doi: 10.1016/j.ejmech.2014.01.049. Epub 2014 Jan 31.

PMID:
24561669
7.

Alleviating pain hypersensitivity through activation of type 4 metabotropic glutamate receptor.

Vilar B, Busserolles J, Ling B, Laffray S, Ulmann L, Malhaire F, Chapuy E, Aissouni Y, Etienne M, Bourinet E, Acher F, Pin JP, Eschalier A, Goudet C.

J Neurosci. 2013 Nov 27;33(48):18951-65. doi: 10.1523/JNEUROSCI.1221-13.2013.

8.

Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain.

Barrière DA, Mallet C, Blomgren A, Simonsen C, Daulhac L, Libert F, Chapuy E, Etienne M, Högestätt ED, Zygmunt PM, Eschalier A.

PLoS One. 2013 Aug 5;8(8):e70690. doi: 10.1371/journal.pone.0070690. Print 2013.

9.

Study of emotional and cognitive impairments in mononeuropathic rats: effect of duloxetine and gabapentin.

Grégoire S, Michaud V, Chapuy E, Eschalier A, Ardid D.

Pain. 2012 Aug;153(8):1657-63. doi: 10.1016/j.pain.2012.04.023. Epub 2012 Jun 2.

PMID:
22664319
10.

Nav1.9 channel contributes to mechanical and heat pain hypersensitivity induced by subacute and chronic inflammation.

Lolignier S, Amsalem M, Maingret F, Padilla F, Gabriac M, Chapuy E, Eschalier A, Delmas P, Busserolles J.

PLoS One. 2011;6(8):e23083. doi: 10.1371/journal.pone.0023083. Epub 2011 Aug 12.

11.

Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia.

Mallet C, Daulhac L, Bonnefont J, Ledent C, Etienne M, Chapuy E, Libert F, Eschalier A.

Pain. 2008 Sep 30;139(1):190-200. doi: 10.1016/j.pain.2008.03.030. Epub 2008 May 15.

PMID:
18485596
12.

Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain.

Goudet C, Chapuy E, Alloui A, Acher F, Pin JP, Eschalier A.

Pain. 2008 Jul;137(1):112-24. Epub 2007 Sep 27.

13.

Acetaminophen recruits spinal p42/p44 MAPKs and GH/IGF-1 receptors to produce analgesia via the serotonergic system.

Bonnefont J, Daulhac L, Etienne M, Chapuy E, Mallet C, Ouchchane L, Deval C, Courade JP, Ferrara M, Eschalier A, Clottes E.

Mol Pharmacol. 2007 Feb;71(2):407-15. Epub 2006 Nov 6.

PMID:
17088403
14.

Age-related impact of neuropathic pain on animal behaviour.

Pickering G, Jourdan D, Millecamps M, Chapuy E, Alliot J, Eschalier A.

Eur J Pain. 2006 Nov;10(8):749-55. Epub 2006 Jan 20.

PMID:
16427791
15.

Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats.

Bourdu S, Dapoigny M, Chapuy E, Artigue F, Vasson MP, Dechelotte P, Bommelaer G, Eschalier A, Ardid D.

Gastroenterology. 2005 Jun;128(7):1996-2008.

PMID:
15940632
17.

Memory impairment means less pain for mice.

Pickering G, Chapuy E, Eschalier A, Dubray C.

Gerontology. 2004 May-Jun;50(3):152-6.

PMID:
15114036
18.
19.

Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats.

Marchand F, Ardid D, Chapuy E, Alloui A, Jourdan D, Eschalier A.

J Pharmacol Exp Ther. 2003 Oct;307(1):268-74. Epub 2003 Sep 3.

PMID:
12954814
20.

Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats.

Marchand F, Alloui A, Chapuy E, Jourdan D, Pelissier T, Ardid D, Hernandez A, Eschalier A.

Pain. 2003 Jun;103(3):229-35. No abstract available.

PMID:
12791429
21.

The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system.

Marchand F, Alloui A, Chapuy E, Hernandez A, Pelissier T, Ardid D, Eschalier A.

Neurosci Lett. 2003 May 15;342(1-2):105-8.

PMID:
12727329
22.
23.

Effect of analgesics on audible and ultrasonic pain-induced vocalization in the rat.

Jourdan D, Ardid D, Chapuy E, Le Bars D, Eschalier A.

Life Sci. 1998;63(20):1761-8.

PMID:
9820120
24.

Audible and ultrasonic vocalization elicited by a nociceptive stimulus in rat: relationship with respiration.

Jourdan D, Ardid D, Chapuy E, Le Bars D, Eschalier A.

J Pharmacol Toxicol Methods. 1997 Oct;38(2):109-16.

PMID:
9403782
25.

Cardiac vagal effects of rilmenidine in the dog: comparison with clonidine.

Boucher M, Dubar M, Chapuy E, Chassaing C.

J Auton Pharmacol. 1997 Apr;17(2):87-90.

PMID:
9234078
26.

Hysteresis in atrial refractoriness in the conscious dog: influence of stimulation parameters and control by the autonomic nervous system.

Boucher M, Chassaing C, Chapuy E, Lorente P.

J Cardiovasc Pharmacol. 1996 Dec;28(6):842-7.

PMID:
8961083
27.

Cardiac electrophysiological effects of falipamil in the conscious dog: comparison with alinidine.

Boucher M, Chassaing C, Chapuy E.

Eur J Pharmacol. 1996 Jun 13;306(1-3):93-8.

PMID:
8813620
28.
29.

Audible and ultrasonic vocalization elicited by single electrical nociceptive stimuli to the tail in the rat.

Jourdan D, Ardid D, Chapuy E, Eschalier A, Le Bars D.

Pain. 1995 Nov;63(2):237-49.

PMID:
8628590
30.
31.

Chronotropic cardiac effects of NPY in conscious dogs: interactions with the autonomic nervous system and putative NPY receptors.

Boucher M, Chassaing C, Chapuy E, Lorente P.

Regul Pept. 1994 Dec 15;54(2-3):409-15.

PMID:
7716274
32.

Chronotropic cardiac effects of falipamil in conscious dogs: interactions with the autonomic nervous system and various ionic conductances.

Boucher M, Chassaing C, Chapuy E, Duchêne-Marullaz P.

J Cardiovasc Pharmacol. 1994 Apr;23(4):569-75.

PMID:
7516006
33.

Membrane stabilizing activity and beta-adrenoceptor antagonist-induced bradycardia in conscious dogs.

Boucher M, Chapuy E, Duchêne-Marullaz P.

Eur J Pharmacol. 1992 Feb 18;211(3):343-9.

PMID:
1352254
34.

Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block.

Boucher M, Chapuy E, Lefebvre MA, Mignot A, Duchêne-Marullaz P.

Naunyn Schmiedebergs Arch Pharmacol. 1989 Jun;339(6):630-7.

PMID:
2570365
35.

Study of histamine release induced by acute administration of antitumor agents in dogs.

Eschalier A, Lavarenne J, Burtin C, Renoux M, Chapuy E, Rodriguez M.

Cancer Chemother Pharmacol. 1988;21(3):246-50.

PMID:
2452032

Supplemental Content

Loading ...
Support Center